184 related articles for article (PubMed ID: 10979354)
1. Achondroplasia in diverse Jewish and Arab populations in Israel: clinical and molecular characterization.
Falik-Zaccai TC; Shachak E; Abeliovitch D; Lerer I; Shefer R; Carmi R; Ries L; Friedman M; Shohat M; Borochowitz Z
Isr Med Assoc J; 2000 Aug; 2(8):601-4. PubMed ID: 10979354
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular characteristics of Thai patients with achondroplasia.
Shotelersuk V; Ittiwut C; Srivuthana S; Wacharasindhu S; Aroonparkmongkol S; Mutirangura A; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2001 Jun; 32(2):429-33. PubMed ID: 11556601
[TBL] [Abstract][Full Text] [Related]
3. A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia.
Stoilov I; Kilpatrick MW; Tsipouras P
Am J Med Genet; 1995 Jan; 55(1):127-33. PubMed ID: 7702086
[TBL] [Abstract][Full Text] [Related]
4. Chinese achondroplasia is also defined by recurrent G380R mutations of the fibroblast growth factor receptor-3 gene.
Niu DM; Hsiao KJ; Wang NH; Chin LS; Chen CH
Hum Genet; 1996 Jul; 98(1):65-7. PubMed ID: 8682509
[TBL] [Abstract][Full Text] [Related]
5. [Mutations in the Fibroblast Growth Factor Receptor 3 gene (FGFR3) in Chilean patients with idiopathic short stature, hypochondroplasia and achondroplasia].
Mancilla EE; Poggi H; Repetto G; García C; Foradori A; Cattani A
Rev Med Chil; 2003 Dec; 131(12):1405-10. PubMed ID: 15022403
[TBL] [Abstract][Full Text] [Related]
6. Achondroplasia in Turkey is defined by recurrent G380R mutation of the FGFR3 gene.
Pehlivan S; Ozkinay F; Okutman O; Coğulu O; Ozcan A; Cankaya T; Ulgenalp A
Turk J Pediatr; 2003; 45(2):99-101. PubMed ID: 12921294
[TBL] [Abstract][Full Text] [Related]
7. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
Ezquieta Zubicaray B; Iguacel AO; Varela Junquera JM; Jariego Fente CM; González Gancedo P; Gracia Bouthelier R
Med Clin (Barc); 1999 Mar; 112(8):290-3. PubMed ID: 10207844
[TBL] [Abstract][Full Text] [Related]
8. [Achondroplasia: molecular study of 28 patients].
Climent C; Lorda-Sánchez I; Urioste M; Gairi JM; Rodríguez JI; Rubio V
Med Clin (Barc); 1998 Apr; 110(13):492-4. PubMed ID: 9611730
[TBL] [Abstract][Full Text] [Related]
9. Achondroplasia is defined by recurrent G380R mutations of FGFR3.
Bellus GA; Hefferon TW; Ortiz de Luna RI; Hecht JT; Horton WA; Machado M; Kaitila I; McIntosh I; Francomano CA
Am J Hum Genet; 1995 Feb; 56(2):368-73. PubMed ID: 7847369
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.
Rousseau F; Bonaventure J; Legeai-Mallet L; Pelet A; Rozet JM; Maroteaux P; Le Merrer M; Munnich A
Nature; 1994 Sep; 371(6494):252-4. PubMed ID: 8078586
[TBL] [Abstract][Full Text] [Related]
11. [Updated treatment of achondroplasia].
Seino Y
Clin Calcium; 2009 Mar; 19(3):432-6. PubMed ID: 19252254
[TBL] [Abstract][Full Text] [Related]
12. An uncommon G375C substitution in a newborn with achondroplasia.
Addor MC; Gudinchet F; Truttmann A; Schorderet DF
Genet Couns; 2000; 11(2):169-74. PubMed ID: 10893668
[TBL] [Abstract][Full Text] [Related]
13. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
Bellus GA; McIntosh I; Smith EA; Aylsworth AS; Kaitila I; Horton WA; Greenhaw GA; Hecht JT; Francomano CA
Nat Genet; 1995 Jul; 10(3):357-9. PubMed ID: 7670477
[TBL] [Abstract][Full Text] [Related]
14. [Detection of fibroblast growth factor receptor 3 gene mutation at nucleotide 1138 site in congenita achondroplasia patients].
Ni J; Lu G; Wang W; Chen F; Qin H; Wang D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):205-8. PubMed ID: 12048679
[TBL] [Abstract][Full Text] [Related]
15. Predominance of the mutation at 1138 of the cDNA for the fibroblast growth factor receptor 3 in Japanese patients with achondroplasia.
Tonoki H; Nakae J; Tajima T; Shinohara N; Monji J; Satoh S; Fujieda K
Jpn J Hum Genet; 1995 Dec; 40(4):347-9. PubMed ID: 8851771
[TBL] [Abstract][Full Text] [Related]
16. Achondroplasia in Sweden caused by the G1138A mutation in FGFR3.
Alderborn A; Anvret M; Gustavson KH; Hagenäs L; Wadelius C
Acta Paediatr; 1996 Dec; 85(12):1506-7. PubMed ID: 9001669
[TBL] [Abstract][Full Text] [Related]
17. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.
Superti-Furga A; Eich G; Bucher HU; Wisser J; Giedion A; Gitzelmann R; Steinmann B
Eur J Pediatr; 1995 Mar; 154(3):215-9. PubMed ID: 7758520
[TBL] [Abstract][Full Text] [Related]
18. An improved methodology for the detection of the common mutation in the FGFR3 gene responsible for achondroplasia.
Lanning RW; Brown CA
Hum Mutat; 1997; 10(6):496-9. PubMed ID: 9401015
[TBL] [Abstract][Full Text] [Related]
19. Genotyping of the G1138A mutation of the FGFR3 gene in patients with achondroplasia using high-resolution melting analysis.
Hung CC; Lee CN; Chang CH; Jong YJ; Chen CP; Hsieh WS; Su YN; Lin WL
Clin Biochem; 2008 Feb; 41(3):162-6. PubMed ID: 18199430
[TBL] [Abstract][Full Text] [Related]
20. [Differentiation of achondroplasia and other similar genetic dwarfism by FGFR3 gene analysis].
Zhang Y; Yu W; Shen M; Fang Q; Fan M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):252-5. PubMed ID: 10932008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
